Matt Karnes is the Founder of GreenWave Advisors and has been helping investors navigate the complexities of the emerging cannabis industry since 2014. Not many analysts have almost a decade of cannabis-investing experience, so I was excited to talk with Matt.
Matt shares his background on the sell side and accounting experience, and then we jump into some of the challenges to expect in 2023 and how we can best navigate them. Compressing prices, higher interest rates, thriving traditional markets, and limited capital are impacting all operators and we discuss who is best suited to survive in 2023 and thrive in the future. Matt's top picks are Green Thumb Industries and Curaleaf.
We conclude by talking about riskier operators and Matt shares why he feels names like AYR and Ascend could face challenges if new markets do not perform as planned. I appreciated Matt's balanced perspective: 2023 may be a challenging year, but the longer-term outlook remains bright.
To listen, you can click the link here or the tweet below. Twitter Spaces will play on any mobile device or on the desktop via a browser. They are like a podcast but hosted on Twitter.
The information in our newsletter may become outdated and we have no obligation to update it. The information in our newsletter is not intended to constitute individual investment advice and is not designed to meet your personal financial situation. It is provided for information purposes only and nothing herein constitutes investment, legal, accounting, or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor or a group of investors. It should not be assumed that any investments in securities, companies, sectors, or markets identified and described were or will be profitable. We strongly advise you to discuss your investment options with your financial adviser prior to making any investments, including whether any investment is suitable for your specific needs.
The information provided in our newsletter is private, privileged, and confidential information, licensed for your sole individual use as a subscriber. Green Giants reserves all rights to the content of this newsletter. Forwarding, copying, disseminating, or distributing this newsletter in whole or in part, including substantial quotation of any portion of the publication or any release of specific investment recommendations, is strictly prohibited.